Promising Results: Transcutaneous Vagus nerve stimulation for therapy resistant epilepsies

**Admin** Sat Jun 18, 2011 6:30 am

Transcutaneous Vagus nerve stimulation for therapy resistant epilepsies

The pilot study into treating therapy resistant epilepsies using NEMOS® confirms the initial, positive, intermediate results from June 2010. NEMOS®, from cerbomed GmbH, is the first device worldwide for transcutaneous Vagus Nerve Stimulation (t-VNS®). The study produced positive indications for safety, tolerability and effectiveness, along with verifying the high user-friendliness of t-VNS®.

A decrease in the frequency and duration of hard to treat epileptic incidences was achieved for 5 of 7 patients using t-VNS®. The director of the clinical trial, Professor Dr. Stefan, explains: "Altogether, t-VNS® can be judged as a safe and compatible method for long-term application. As such, it represents a possible therapy alternative for patients with hard to treat epilepsies."

"The result of the pilot study is another important milestone for our company. It motivates us to carry out a worldwide, multi-center study for t-VNS® therapy from the middle of the year, and lays the foundation stone for a successful market launch," says Prof. Dr. Jens Ellrich, Chief Medical Officer at cerbomed.

Source:Transcutaneous Vagus nerve stimulation
Promising Results: Transcutaneous Vagus nerve stimulation for therapy resistant epilepsies Cmlogo

Promising Results: Transcutaneous Vagus nerve stimulation for therapy resistant epilepsies Cmlogo

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30